Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical ...

Greetings, and welcome to the Panbela Therapeutics ... a term loan from the lender in the original principal amount of $1.5 million. The loan proceeds were used by the company for payment of fees and ...

The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

Revenues in the fiscal second quarter of 2025 decreased 3% to $201,000, largely due to decreased sales to veterinary clinics. The decrease was partially offset by a 24% increase in sales to ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

Notes payable, plus accrued interest, totaled approximately $6.9 million. The current portion of the notes payable plus accrued interest totaled approximately $3.7 million. Included in the current ...

The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

14, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics ... the progress and future expectations and goals of our research and development, preclinical and clinical trial activities, and partnering and ...

POTOMAC, MD / ACCESSWIRE / November 14, 2024 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced its financial results and strategic advancements for the second fiscal ...

Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectableCompany ...

Good morning, and welcome to Mersana Therapeutics third quarter 2024 conference Call. (Operator Instructions) Please note this event is being recorded ... I'm pleased to report that Mersana made ...

13, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. ("Oruka”) (Nasdaq ... closing on over $475 million in proceeds across ...